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Summary
Immunosurveillance requires the migration of lymphocytes and their
activation to induce proliferation and effector function. Effective immunity
requires an optimal supply of nutrients to lymphocytes. Cells contain
nutrient sensing apparatus such as adenosine 50-monophosphate-activated
protein kinase (AMPK) that surveys intracellular ATP levels. Immunity
declines during ageing and one possibility is that the energy balance may be
altered in old lymphocytes. This paper summarizes recent data identifying a
convergence of senescence and nutrient signalling pathways in lymphocytes
that inhibit both T cell and natural killer (NK) cell function during ageing.
Significantly, these pathways can be inhibited to enhance the activity of
these cells.
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Convergence of senescence and nutrient sensing in
regulating senescent T cell function
Senescent human T cells can be identified by multiple phe-
notypical and functional parameters, including increased
evidence of DNA damage, constitutive activation of p38
mitogen-activated protein (MAP) kinase, short telomeres,
loss of telomerase activity and decreased proliferative activity
after activation [1]. These cells also lose expression of co-
stimulatory molecules such as CD27 and CD28, but re-
express the naive marker CD45RA and increase during age-
ing [1]. It was shown recently that the decreased proliferative
activity and decreased ability to induce telomerase after acti-
vation was not a passive response due to cellular dysfunc-
tion; instead, this was an actively maintained state that
resulted from p38 MAP kinase signalling [2]. The inhibition
of p38 using a small molecule inhibitor enhanced both the
proliferation and telomerase activity of T cells after activa-
tion [2]. The unexpected observation was that the constitu-
tive p38 activation in senescent human CD41 T cells was
induced by a novel mechanism that involved activation of
the metabolic sensor 5-monophosphate activated protein
kinase (AMPK) that is activated by low levels of intracellular
adenosine triphosphate (ATP) [3]. The senescent T cells also
exhibited constitutive AMPK activation. The deprivation of
non-senescent T cells of glucose also induced AMPK and
p38 activation, leading to a decrease in both telomerase
activity and proliferation of these cells, mimicking the func-
tional phenotype of senescent T cells. This showed an inex-
tricable link between the ageing of T cells and their
bioenergetics status. The inhibition of AMPK, p38 or a scaf-
fold molecule transforming growth factor beta (TGF-b)-
activated kinase binding protein 1 (TAB1), that are found
together in a macromolecular complex, enhanced both pro-
liferative activity and telomerase induction in senescent or
nutrient-starved T cells [3]. The implications of this include
decreased functional activity of T cells in environments that
are depleted of nutrients, e.g. in the vicinity of a tumour [4].
This may be exacerbated during ageing, as older individuals
have increased proportions of senescent cells within the T
cell compartment and nutrient deprivation in these cells
may exacerbate dysfunctional anti-tumour activity.
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Furthermore, a novel way to enhance immunity during age-
ing may be to modulate the nutrient status of older individ-
uals rather than to target immunity directly [5].
How do senescent T cells obtain their energy?
Senescent CD81 T cells exhibit mitochondrial dysfunction,
increased production of reactive oxygen species (ROS) and
impaired mitochondrial biogenesis [6]. It was shown that
human senescent CD81 T cells utilize glycolysis preferentially
to generate ATP, in contrast to the effector memory subset,
which is much more metabolically flexible and can either
use glycolysis or oxidative phosphorylation (OXPHOS) for
functional activities [6]. One possibility is that the depend-
ence upon glycolysis results from mitochondrial dysfunction
[6]. As p38 inhibition enhances proliferative activity of senes-
cent CD81 T cells, it raises the question of how the energy for
this enhanced activity is acquired and the implications that
this has for mitochondrial function. When p38 signalling was
inhibited in senescent human CD81 T cells, autophagy was
increased and cleared dysfunctional mitochondria, and this
reduced mitochondrial ROS production [6]. This occurred
by a process involving increased trafficking of the autophagy
regulating protein 9 (Atg9) from the endosomes to the lyso-
somes [6]. However, despite the increased mitochondrial fit-
ness, senescent T cells still utilize glycolysis, and not
OXPHOS, preferentially for increased proliferation after p38
blockade. Therefore, mitochondrial dysfunction is not the
main reason why these cells are dependent upon glycolysis for
generating energy. These results reinforce the observations
that senescence and nutrient sensing pathways are linked
inextricably and can control the function of T cells.
Killer cell lectin-like receptor G1 (KLRG1) inhibitory
receptor activates AMPK to inhibit natural killer (NK)
cell function during ageing
NK cells are a first line of defence during infection and in
the response to tumours. NK activity declines during ageing
[7], and this may contribute to age-associated immune
decline. A possible reason for decreased NK activity may be
through inhibition of the cells by ligation of cell surface
inhibitory receptors. One such inhibitory receptor, KLRG1,
increases on NK cells in individuals aged >70 years and cells
with high KLRG1 express AMPK constitutively [8]. Further-
more, KLRG1 activates AMPK by preventing its inactivation
by the enzyme PP2C rather than by de-novo activation of
AMPK itself. The inhibition of KLRG1 or AMPK enhanced
NK cell cytotoxicity, cytokine production, proliferation and
telomerase activity. Therefore, inhibitory receptor signalling
in NK cells down-regulate effector function through an
AMPK-dependent process that links nutrient sensing to
functional activity in NK cells of older subjects. KLRG1 is
also increased in CD81 T cells of older individuals, raising
the possibility that a similar process may be involved in these
cells. It is not known if this KLRG1/AMPK inhibitory path-
way requires p38 MAP kinase for its activation or if this
pathway is shared with other inhibitor receptors that can be
found on T cells such as programmed death 1 (PD-1) and
cytotoxic T lymphocyte antigen 4 (CTLA-4). Nevertheless,
these observations suggest that inhibitory cell signalling and
energy-sensing pathways converge to inhibit the function of
highly differentiated NK as well as T cells. More importantly,
this inhibitor pathway can be targeted at different points to
enhance functional responses that may be exploited to
enhance immunity during ageing.
Conclusion
The studies outlined above highlight that decreased T and NK
cell function in older humans can be regulated by convergent
pathways that are initiated by senescence, nutrient deprivation
or cell surface inhibitory receptor signalling. Importantly the
inhibition of upstream or downstream components of this
signalling cascade can enhance both T and NK function. It
remains to be determined whether similar mechanisms can
also regulate B cell function during ageing. These results sug-
gest collectively that, in future, it may be possible to enhance
immune reactivity during ageing by intervention in nutrient-
dependent signalling pathways. These observations also
underscore the potential role of dietary intervention to main-
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